Bispecific prodrug nanoparticles circumventing multiple immune resistance mechanisms for promoting cancer immunotherapy.

导出 LinkOut

翻译打印收藏纠错

作者： Jiayi,Ye ^[1] ; Bo,Hou ^[2] ; Fangmin,Chen ^[1] ; Shunan,Zhang ^[3] ; Muya,Xiong ^[1] ; Tianliang,Li ^[2] ; Yechun,Xu ^[1] ; Zhiai,Xu ^[3] ; Haijun,Yu ^[2]

作者单位： State Key Laboratory of Drug Research & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China. ^[1] University of Chinese Academy of Sciences, Beijing 100049, China. ^[2] School of Chemistry and Molecular Engineering, East China Normal University, Shanghai 200241, China. ^[3] CAS Key Laboratory of Receptor Research, and Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201210, China. ^[4] School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310013, China. ^[5]

关键词 Immune evasion Immunogenic cell death Immunotherapy Prodrug nanoparticles Tumor microenvironment

DOI 10.1016/j.apsb.2021.09.021

PMID 35755274

发布时间 2022-07-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Acta pharmaceutica Sinica. B

2022年12卷6期

2695-2709页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Bispecific prodrug nanoparticles circumventing multiple immune resistance mechanisms for promoting cancer immunotherapy.

Acta pharmaceutica Sinica. B

相似文献

Acta pharmaceutica Sinica. B

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Bispecific prodrug nanoparticles circumventing multiple immune resistance mechanisms for promoting cancer immunotherapy.

Acta pharmaceutica Sinica. B

相似文献

Acta pharmaceutica Sinica. B

相关期刊

检索历史清除